Health54

Health54 is a corporate venture capital firm based in Boulogne-Billancourt, France, investing in innovative health tech and services startups across Africa to enhance access to reliable, affordable healthcare. Established in January 2022 by CFAO SAS, a subsidiary of the CFAO Group and Toyota Tsusho, it operates as a permanent €10 million investment vehicle. The firm leverages CFAO Healthcare's extensive pan-African operations, which span 28 countries, to support its portfolio companies with both capital and strategic resources in pharmaceuticals and healthcare distribution. Its first notable investment was leading a $3 million pre-Series A round for Lifestores Healthcare in October 2022, a company co-led by Bryan Mezue and Andrew Garza. Health54, under CEO Côme Vercken, actively seeks solutions for healthcare management, supply chain, telemedicine, financing, and digital transformation, having also launched a Digital Transformation Challenge for African healthcare startups in 2022.

High-Level Overview

Health54 is a corporate venture capital (CVC) arm established by the CFAO Group, itself a subsidiary of Toyota Tsusho, with a mission to accelerate innovation in Africa’s healthcare sector. Its investment philosophy centers on backing early-stage startups that leverage technology to solve pressing social challenges, particularly in access to quality and affordable healthcare. Health54 focuses on healthtech, digital transformation, and scalable service platforms across Africa’s 54 countries. By providing both capital and strategic support, Health54 aims to catalyze growth in startups that can drive systemic improvements in healthcare delivery, while also fostering synergies with CFAO’s broader healthcare and mobility operations.

Origin Story

Founded in January 2022 and headquartered in Boulogne-Billancourt, France, Health54 was created as part of CFAO Group’s strategic push to deepen its impact in African healthcare. The venture was launched with €10 million in capital and is led by CEO Côme Vercken. Health54’s formation followed CFAO’s expansion into pharmaceutical retail in Africa, including its investment in Goodlife Pharmacies in Kenya. The first major investment was a US$3 million pre-Series A round in Lifestores Healthcare, a Nigerian healthtech startup, marking Health54’s entry into the African startup ecosystem. This move signaled a shift from traditional healthcare operations to active venture building, with a focus on innovation and digital transformation.

Core Differentiators

• Corporate Venture Capital Model: Health54 leverages the resources, networks, and operational expertise of CFAO and Toyota Tsusho, enabling it to offer more than just capital—startups gain access to distribution channels, supply chain infrastructure, and regional market knowledge.
• Strategic Focus on Africa: Unlike generalist funds, Health54 is dedicated exclusively to African healthtech and healthcare services, with a deep understanding of local challenges and opportunities.
• Synergy with Mobility54: Health54 operates alongside Mobility54, Toyota Tsusho’s mobility-focused CVC, allowing for cross-sector collaboration and holistic solutions to urban and rural healthcare access.
• Active Ecosystem Building: Health54 supports startups not only through funding but also by facilitating partnerships, scaling operations, and driving digital transformation across the continent.

Role in the Broader Tech Landscape

Health54 is riding the wave of Africa’s digital health revolution, where mobile penetration, fintech innovation, and rising demand for affordable healthcare are converging. The timing is critical, as African governments and private sector players increasingly recognize the need for scalable, tech-driven solutions to bridge healthcare gaps. Health54’s investments, such as in Lifestores Healthcare, exemplify how digital platforms can transform pharmacy management, patient access, and credit systems in underserved markets. By supporting startups that blend healthtech with fintech and supply chain innovation, Health54 is helping to shape a more resilient and inclusive healthcare ecosystem across Africa.

Quick Take & Future Outlook

Health54 is poised to become a key catalyst for healthtech innovation in Africa, with its unique blend of corporate backing, regional expertise, and strategic vision. As the continent’s healthcare needs continue to grow, Health54’s ability to identify and scale transformative startups will be crucial. Future investments are likely to focus on AI-driven diagnostics, telemedicine, and integrated care platforms, further deepening the impact of digital health across Africa. Health54’s journey reflects a broader trend: the rise of corporate venture capital as a force for social and technological change in emerging markets.